125 related articles for article (PubMed ID: 6882628)
1. Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.
Bellamy GR; Hunyor SN; Roffe D; Massang J
Br J Clin Pharmacol; 1983 Jul; 16(1):9-16. PubMed ID: 6882628
[TBL] [Abstract][Full Text] [Related]
2. Anti-hypertensive action of labetalol: a detailed profile.
Bellamy GR; Hunyor SN; Roffe D; Massang J
Aust N Z J Med; 1982 Oct; 12(5):467-72. PubMed ID: 6758743
[TBL] [Abstract][Full Text] [Related]
3. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
4. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
[TBL] [Abstract][Full Text] [Related]
5. Effect of labetalol in hypertension during exercise and postural changes.
Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
7. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
Sanders GL; Murray A; Rawlins MD
Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
[TBL] [Abstract][Full Text] [Related]
8. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
Frick MH; Pörsti P
Br Med J; 1976 May; 1(6017):1046-8. PubMed ID: 773498
[TBL] [Abstract][Full Text] [Related]
9. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
Hunyor SN; Bauer GE; Ross M; Larkin H
Aust N Z J Med; 1980 Apr; 10(2):162-6. PubMed ID: 6930206
[TBL] [Abstract][Full Text] [Related]
10. Labetalol in resistant hypertension.
Hedstrand H
Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
[TBL] [Abstract][Full Text] [Related]
11. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of intravenous labetalol in essential hypertension.
Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ; Nassim M; Armstrong BK; Beilin L
Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
[TBL] [Abstract][Full Text] [Related]
15. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
Barnett AJ; Kalowski S; Guest C
Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
[TBL] [Abstract][Full Text] [Related]
16. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
[TBL] [Abstract][Full Text] [Related]
17. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
18. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
[TBL] [Abstract][Full Text] [Related]
19. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
Michelson EL; Frishman WH
Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined alpha- and beta-receptor blockade on peripheral circulation in essential hypertension.
Heck I; Trübestein G; Stumpe KO
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():429s-432s. PubMed ID: 7318348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
